Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings

4.37
-0.3950-8.30%
Post-market: 4.370.00000.00%19:19 EDT
Volume:39.57K
Turnover:175.97K
Market Cap:17.59M
PE:-0.46
High:4.99
Open:4.89
Low:4.18
Close:4.76
52wk High:75.50
52wk Low:4.18
Shares:4.03M
Float Shares:507.23K
Volume Ratio:0.92
T/O Rate:7.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.4069
EPS(LYR):-3.5022
ROE:--
ROA:-439.67%
PB:-1.06
PE(LYR):-1.25

Loading ...

BRIEF-Tevogen Advances Strategic CRO Evaluation To Expand Clinical Research Delivery Capabilities And Drive Revenue Growth

Reuters
·
Mar 27

Tevogen Bio Holdings: Opportunity Expected to Contribute More Than $20 Mln in Annual Revenue While Supporting Double-Digit Growth Beginning Next Year

THOMSON REUTERS
·
Mar 27

Tevogen Advances Strategic Cro Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

THOMSON REUTERS
·
Mar 27

Tevogen Bio implements 1-for-50 reverse stock split; Nasdaq bid-price compliance returns

Reuters
·
Mar 26

Tevogen Bio Regains Compliance With Nasdaq Listing Rule

MT Newswires Live
·
Mar 26

Tevogen regains compliance with Nasdaq minimum bid price requirement

TIPRANKS
·
Mar 26

Tevogen Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
Mar 26

Tevogen Bio Holdings Inc expected to post a loss of $2.00 a share - Earnings Preview

Reuters
·
Mar 24

Tevogen CIO Mittul Mehta to Speak at Microsoft Fabric Community Conference FabCon 2026

Reuters
·
Mar 19

Tevogen Bio Holdings - Lead Investor Confirmed Intention to Maintain Current Shareholdings

THOMSON REUTERS
·
Mar 14

Tevogen Bio Holdings Inc - Board Continues to Evaluate Potential One-Time Special Cash Dividend

THOMSON REUTERS
·
Mar 14

Tevogen Bio says it will use no more than 1% of authorized shares over the next 12 months

Reuters
·
Mar 14

BUZZ - US STOCKS ON THE MOVE-Kyivstar Group, Applied Materials, Tevogen Bio

Reuters
·
Mar 14

BUZZ-Tevogen rises as AI platform upgrade boosts drug discovery push

Reuters
·
Mar 14

Tevogen reports performance advancements for Tevogen.AI platform

TIPRANKS
·
Mar 14

Tevogen reports PredicTcell Beta recall at 92% and precision at 48%

Reuters
·
Mar 14

Tevogen.AI Reports Advancements in Predictcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

THOMSON REUTERS
·
Mar 14

Tevogen Bio Holdings Inc - Evaluating Acquisition of Sciometrix and Clinicus Platform for Long Covid Monitoring

THOMSON REUTERS
·
Mar 12

Tevogen accelerates TVGN 489 Long COVID program as HLA coverage reaches 65% of U.S. population

Reuters
·
Mar 12

Tevogen appoints interim leaders across core business verticals

TIPRANKS
·
Mar 09